Kibum Kim Selected Research

Kibum Kim Research Topics

Disease

12	Neoplasms (Cancer) 05/2024 - 01/2017
4	Breast Neoplasms (Breast Cancer) 05/2024 - 02/2020
3	Hemorrhage 01/2023 - 10/2019
3	Atrial Fibrillation 10/2020 - 11/2019
3	Acute Coronary Syndrome 08/2018 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2023
2	Heart Failure 11/2023 - 04/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2021
2	Starvation 01/2022 - 10/2020
2	Venous Thromboembolism 11/2019 - 10/2019
2	Type 2 Diabetes Mellitus (MODY) 03/2019 - 01/2019
1	Pain (Aches) 03/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2024
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2024
1	Cardiomyopathies (Cardiomyopathy) 11/2023
1	Lymphoma (Lymphomas) 09/2023
1	Prostatic Neoplasms (Prostate Cancer) 07/2023
1	Sudden Infant Death (SID) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Thromboembolism 10/2020
1	Polymorphic catecholergic ventricular tachycardia 01/2020
1	Thrombosis (Thrombus) 11/2019
1	Invasive Fungal Infections 10/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Critical Illness (Critically Ill) 02/2018
1	Rheumatoid Arthritis 01/2018
1	ST Elevation Myocardial Infarction 01/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2021
3	Lenalidomide (CC 5013)FDA Link 09/2023 - 01/2022
3	tafasitamabIBA 09/2023 - 01/2022
3	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 10/2019
3	TicagrelorIBA 08/2018 - 01/2017
3	Clopidogrel (Plavix)FDA Link 08/2018 - 01/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2018 - 01/2017
3	Prasugrel Hydrochloride FDA Link 08/2018 - 01/2017
2	Monoclonal AntibodiesIBA 05/2024 - 03/2024
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
2	polatuzumab vedotinIBA 09/2023 - 07/2023
2	Rituximab (Mabthera)FDA Link 09/2023 - 07/2023
2	Bendamustine Hydrochloride FDA Link 09/2023 - 07/2023
2	VaccinesIBA 07/2023 - 01/2021
2	AntigensIBA 07/2023 - 11/2022
2	Glutamine (L-Glutamine)FDA Link 01/2023 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 11/2022 - 01/2021
2	Epithelial Cell Adhesion MoleculeIBA 11/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2019
2	Leucine (L-Leucine)FDA Link 01/2022 - 10/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2019 - 01/2019
1	Trastuzumab (Herceptin)FDA Link 05/2024
1	human ERBB2 proteinIBA 05/2024
1	Estrogen ReceptorsIBA 04/2024
1	P-SelectinIBA 03/2024
1	crizanlizumabIBA 03/2024
1	Small Cytoplasmic RNAIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Prealbumin (Transthyretin)IBA 11/2023
1	Technetium Tc 99m PyrophosphateIBA 11/2023
1	Amyloid (Amyloid Fibrils)IBA 11/2023
1	tafamidisIBA 11/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 07/2023
1	prostatic acid phosphataseIBA 07/2023
1	SodiumIBA 04/2023
1	Calcium Channels (Calcium Channel)IBA 04/2023
1	Pregabalin (Lyrica)FDA Link 04/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Cancer VaccinesIBA 11/2022
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	Autophagy-Related Protein-1 HomologIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 02/2020
1	ImmunosorbentsIBA 02/2020
1	EnzymesIBA 02/2020
1	Single-Domain AntibodiesIBA 02/2020
1	Tetrodotoxin (Tetradotoxin)IBA 01/2020
1	CatecholaminesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	AnticoagulantsIBA 10/2019
1	Hemoglobins (Hemoglobin)IBA 03/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	MTOR InhibitorsIBA 01/2017

Therapy/Procedure

6	Therapeutics 09/2023 - 10/2019
2	Percutaneous Coronary Intervention 08/2018 - 01/2017
1	Immunotherapy 07/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Hematopoietic Stem Cell Transplantation 10/2019
1	Artificial Respiration (Mechanical Ventilation) 02/2018